COLOMA JASON V (Chief Executive Officer) sold 8.0% of their position (27.86K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $725.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/24/2026ACC: 0001676170-26-000012
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-27.86K
Net shares
Net seller
$725.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
27.86K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−1.95K
Price / share
$26.00
Trade value
$50.78K
% of position
0.6%
6/22/2026
344.90K→342.94K
Common Stock
Indirect
Shares
−2.04K
Price / share
$26.00
Trade value
$53.04K
% of position
7.3%
6/22/2026
27.97K→25.93K
Common Stock
Indirect
Shares
−23.86K
Price / share
$26.05
Trade value
$621.67K
% of position
7.0%
6/23/2026
342.94K→319.08K
Total
Net shares
−27.86K
Net value
-$725.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/22/2026 | S · Sale | −1.95K | $26.00 | $50.78K | 0.6% | 344.90K | 342.94K |
| Common Stock Indirect | 6/22/2026 | S · Sale | −2.04K | $26.00 | $53.04K | 7.3% | 27.97K | 25.93K |
| Common Stock Indirect | 6/23/2026 | S · Sale | −23.86K | $26.05 | $621.67K | 7.0% | 342.94K | 319.08K |
| Total | −27.86K | -$725.49K | ||||||
Derivative Transactions0
No derivative transactions reported